Case studies of FDA recently approved product applications using real-world evidence-What are the attributes of studies that support effectiveness determinations?

被引：0
|
作者：
Li, Jie [1 ]
Dal Pan, Gerald J. [2 ]
机构：
[1] US FDA, Silver Spring, MD USA
[2] FDA, Silver Spring, MD USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
325
引用
收藏
页码：145 / 146
页数：2
相关论文
共 50 条
  • [31] Biases in Evaluating the Safety and Effectiveness of Drugs for the Treatment of COVID-19: Designing Real-World Evidence Studies
    Renoux, Christel
    Azoulay, Laurent
    Suissa, Samy
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2021, 190 (08) : 1452 - 1456
  • [32] EXAMINE THE USE OF REAL-WORLD EVIDENCE TO SUPPORT FDA DECISION-MAKING FOR NEW DRUG APPLICATIONS AND BIOLOGICS LICENSE APPLICATIONS FROM 2021 TO 2022
    Cheng, C. H.
    Farley, J. F.
    VALUE IN HEALTH, 2024, 27 (06) : S216 - S216
  • [33] Calibrating real-world evidence studies against randomized trials: Treatment effectiveness of infliximab in inflammatory bowel disease
    Kirchgesner, Julien
    Desai, Rishi J.
    Schneeweiss, Maria C.
    Beaugerie, Laurent
    Kim, Seoyoung C.
    Schneeweiss, Sebastian
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 41 - 42
  • [34] A Framework for Extension Studies Using Real-World Data to Examine Long-Term Safety and Effectiveness
    Mehmet Burcu
    Cyntia B. Manzano-Salgado
    Anne M. Butler
    Jennifer B. Christian
    Therapeutic Innovation & Regulatory Science, 2022, 56 : 15 - 22
  • [35] A Framework for Extension Studies Using Real-World Data to Examine Long-Term Safety and Effectiveness
    Burcu, Mehmet
    Manzano-Salgado, Cyntia B.
    Butler, Anne M.
    Christian, Jennifer B.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2022, 56 (01) : 15 - 22
  • [36] Two Real-World Case Studies on 3D Web Applications for Participatory Urban Planning
    Alatalo, Toni
    Pouke, Matti
    Koskela, Timo
    Hurskainen, Tomi
    Florea, Ciprian
    Ojala, Timo
    WEB3D 2017, 2017,
  • [37] The utility of real-world evidence for benefit-risk assessment, communication, and evaluation of pharmaceuticals: Case studies
    Radawski, Christine A.
    Hammad, Tarek A.
    Colilla, Susan
    Coplan, Paul
    Hornbuckle, Kenneth
    Freeman, Emily
    Smith, Meredith Y.
    Sobel, Rachel E.
    Bahri, Priya
    Arias, Ariel E.
    Bennett, Dimitri
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (12) : 1532 - 1539
  • [38] Real-World Evidence in Healthcare Decision Making: Global Trends and Case Studies From Latin America
    Justo, Nahila
    Espinoza, Manuel A.
    Ratto, Barbara
    Nicholson, Martha
    Rosselli, Diego
    Ovcinnikova, Olga
    Marti, Sebastian Garcia
    Ferraz, Marcos B.
    Langsam, Martin
    Drummond, Michael F.
    VALUE IN HEALTH, 2019, 22 (06) : 739 - 749
  • [39] A review of the latest real-world evidence studies in diabetic kidney disease: What have we learned about clinical practice and the clinical effectiveness of interventions?
    Bonnet, Fabrice
    Cooper, Mark E.
    Kopp, Laetitia
    Fouque, Denis
    Candido, Riccardo
    DIABETES OBESITY & METABOLISM, 2024, 26 : 55 - 65
  • [40] A NOVEL SPIRAL APPROACH TO INTRODUCTORY CHEMISTRY USING CASE-STUDIES OF CHEMISTRY IN THE REAL-WORLD
    BRINK, CP
    GOODNEY, DE
    HUDAK, NJ
    SILVERSTEIN, TP
    JOURNAL OF CHEMICAL EDUCATION, 1995, 72 (06) : 530 - 532
12345